If XNPT's drug (829) were further along it may fit the bill then they would be fighting with Biogen again in the oral space :-). Still I would think it may be a tad less than 6-7, maybe 3-4 :-), if they could go the 505 route. I sold my position last year so haven't kept up.
Can you give me your thoughts on the $VSTA Pipeline and Tech (link below) - http://www.vistagen.com/?page_id=11 and the RECENT PArtnerships.
I am looking for PROFESSIONAL BIOTECH Traders to give me some quality takes on what $VSTA has going on. I am considering adding BIGTIME before we break $.80
Market Data 
Markets 
AI
